Human Cadherin-9 / CDH9 Protein, His Tag
分子別名（Synonym）
Cadherin-9,CDH9
表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）
Human Cadherin-9, His Tag (CA9-H52H6) is expressed from human 293 cells (HEK293). It contains AA Gly 54 - Ala 615 (Accession # Q9ULB4-1).
蛋白結(jié)構(gòu)（Molecular Characterization）
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 64.5 kDa. The protein migrates as 70-80 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素（Endotoxin）
Less than 1.0 EU per μg by the LAL method.
純度（Purity）
>90% as determined by SDS-PAGE.
制劑（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景（Background）
Cadherin-9（CDH9）是鈣粘蛋白超家族細(xì)胞表面糖蛋白的成員，最初被鑒定為介導(dǎo)細(xì)胞間粘附的蛋白質(zhì)。鈣粘蛋白是一大類細(xì)胞間粘附分子，參與多種細(xì)胞類型的細(xì)胞間粘附。在神經(jīng)系統(tǒng)中，鈣粘蛋白對發(fā)育的所有階段都至關(guān)重要，包括神經(jīng)管與外胚層的早期分離、神經(jīng)元和軸突的分離以及突觸的形成。
關(guān)鍵字： Cadherin-9;CDH9蛋白;CDH9重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。